Filing Details
- Accession Number:
- 0001055726-21-000036
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-21 17:03:08
- Reporting Period:
- 2021-04-21
- Accepted Time:
- 2021-04-21 17:03:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1055726 | Inovio Pharmaceuticals Inc. | INO | Surgical & Medical Instruments & Apparatus (3841) | 330969592 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1669080 | B. David Weiner | 660 W. Germantown Pike Suite 110 Plymouth Meeting PA 19462 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-04-21 | 22,500 | $2.40 | 877,719 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-21 | 22,500 | $8.57 | 855,219 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-04-21 | 4,083 | $8.54 | 851,136 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Options | Disposition | 2021-04-21 | 22,500 | $0.00 | 22,500 | $2.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2012-02-23 | 2022-02-23 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- These transactions were executed in multiple trades at prices ranging from $8.49 to $8.66, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of Restricted Stock Units granted by the issuer.
- Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014.
Billionaire Hedge Funds
